Skip to main content
European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

A patient-centered early risk prediction, prevention, and intervention platform to support the continuum of care in coronary artery disease (CAD) using eHealth and artificial intelligence

Descrizione del progetto

App alimentate da intelligenza artificiale per un cuore sano

Negli ultimi 25 anni, in Europa, il numero assoluto dei casi di malattie cardiovascolari è aumentato. Le malattie cardiovascolari attualmente causano 3,9 milioni di morti in Europa ogni anno e sono responsabili del 45 % delle morti totali. Dal momento che la coronaropatia si sviluppa lentamente, di solito nel corso di decenni, è importante migliorare le previsioni di rischio individuale per la progressione della malattia. Il progetto TIMELY, finanziato dall’UE, svilupperà una piattaforma corredata di app e dashboard alimentati da intelligenza artificiale nonché strumenti d’ausilio alle decisioni per assistere pazienti e medici per personalizzare l’assistenza sanitaria sulla base della valutazione del rischio. Sulla base di una piattaforma funzionale e interoperativa, il progetto semplificherà la condivisione di dati e monitorerà e valuterà i rischi in modo continuo.

Obiettivo

Coronary artery disease (CAD) remains the leading cause of disease burden globally. CAD develops slowly, usually over decades, and depends on multiple (often modifiable) risk factors and their interactions. Self-management and patient activation are of rising importance as current restrictions in healthcare budgets impose great difficulties to enable the provision of qualitative secondary prevention to all cardiac patients in an era facing a huge cardiovascular disease epidemic.
The main hypothesis in the patient-centered TIMELY pathway, is that a modular, collaborative eHealth platform, supported by Artificial Intelligence (AI) for the continuous and in-time prediction of cardiac risks and complications and the induction of targeted behavioural change interventions, can be effective and cost-efficient for the secondary prevention of CAD by limiting the physiological and psychological effects of the disease and improving risk factor and symptom management. Improvements in patients’ self-care and empowerment and clinicians’ efficiency are also expected.
Along the continuum of the disease, prediction of the individual risk for disease progression, including physical impairment and severe events, is mandatory for timely intervention. TIMELY is a platform that provides AI-powered apps and dashboards and decision support tools assisting patients and clinicians to personalize healthcare based on risk evaluation, outcome prediction and tailored interventions. The platform will be developed based on a functional platform for Interoperability with electronic health records and security mechanisms, to ensure information completeness and continuity and to simplify data sharing. AI in TIMELY, built with big retrospective datasets of >23.000 CAD patients, will constantly monitor and evaluate risks and will indicate any deviation from defined therapy goals or unfavorable changes as well as propose proper interventions.

Parole chiave

Invito a presentare proposte

H2020-SC1-DTH-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-SC1-DTH-2020-1

Meccanismo di finanziamento

RIA - Research and Innovation action

Coordinatore

UNIVERSITEIT VAN AMSTERDAM
Contribution nette de l'UE
€ 845 442,50
Indirizzo
SPUI 21
1012WX Amsterdam
Paesi Bassi

Mostra sulla mappa

Regione
West-Nederland Noord-Holland Groot-Amsterdam
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 845 442,50

Partecipanti (16)